Study: Brentuximab vedotin effective, safe in elderly Hodgkin lymphoma patients
A study, published online in Blood, the Journal of the American Society of Hematology (ASH), reports that bretuximab vedotin is an effective and safe first course of treatment for older Hodgkin lymphoma patients unfit for ...
Sep 21, 2015